Filtered By:
Source: Heart Rhythm
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 406 results found since Jan 2013.
Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices
CHA2DS2-VASc is a validated score for predicting stroke in patients with atrial fibrillation (AF).
Source: Heart Rhythm - February 22, 2018 Category: Cardiology Authors: Giovanni Rovaris, Francesco Solimene, Antonio D'Onofrio, Gabriele Zanotto, Renato P. Ricci, Tiziana Mazzella, Saverio Iacopino, Paolo Della Bella, Giampiero Maglia, Gaetano Senatore, Fabio Quartieri, Mauro Biffi, Antonio Curnis, Valeria Calvi, Antonio Rap Source Type: research
Mining the electronic medical record in patients with atrial fibrillation
I found several interesting nuggets of information in the new atrial fibrillation (AF) and stroke analysis from Patel et al1 published in this issue of HeartRhythm, starting with their use of the electronic medical record (EMR) to ask clinical questions. Most of us have a love-hate relationship with our EMR, but the undeniable truth is that it is here to stay. As you invest another late evening or the weekend catchi ng up with your EMR, how often have you wondered whether you can put all this documentation to scientific use? Certainly this is a laudable goal, but, in real life, easier said than done.
Source: Heart Rhythm - February 19, 2018 Category: Cardiology Authors: Sumeet S. Chugh Tags: Editorial Commentary Source Type: research
Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review
Identifying patients who are likely to achieve and maintain a therapeutic international normalized ratio when prescribed a vitamin K antagonist for stroke prevention in atrial fibrillation (AF) and venous thromboembolism (VTE) is challenging. The SAMe-TT2R2 score was developed on the basis of common clinical factors that can highlight patients who may be unable to achieve and maintain good anticoagulation control and for whom a “trial of warfarin” would be inadvisable. This review summarizes the main published prospective and retrospective studies that have validated the SAMe-TT2R2 score in patients with AF and VTE tre...
Source: Heart Rhythm - November 24, 2017 Category: Cardiology Authors: Hanis Zulkifly, Gregory Y.H. Lip, Deirdre A. Lane Tags: Contemporary Review Source Type: research
Screening for Atrial Fibrillation using Smartphone-based Technology and Layperson Volunteers: High-Tech Meets Community Participatory Research for the Best of Both Worlds
Atrial fibrillation (AF), usually asymptomatic and not previously-diagnosed, increases risk of stroke by five times1 and accounts for 15-25% of strokes. 2 Asymptomatic AF is estimated to affect 600,000 Americans, with an estimated cost of 3 billion dollars per year.3 Just because we can identify a risk factor does not mean screening for it will save lives. AF, however, meets most criteria laid out in the World Health Organization ’s manifesto on screening, “Principles and Practice of Screening for Disease”.
Source: Heart Rhythm - July 4, 2018 Category: Cardiology Authors: Rachel Lampert Source Type: research
Feasibility of Left Atrial Appendage Device Closure Following Chronically Failed Surgical Ligation
Incomplete surgical left atrial appendage occlusion (S-LAAO) with a narrow neck has been shown to predict an increased rate of embolic stroke. Patients with a previously attempted S-LAAO were systematically excluded from all clinical trials of LAA closure devices.
Source: Heart Rhythm - July 15, 2018 Category: Cardiology Authors: Christopher R. Ellis, Mohamed Metawee, Robert N. Piana, Jeremy M. Bennett, Mias Pretorius, Robert J. Deegan Source Type: research
Silent cerebral embolism in cryoballoon ablation of atrial fibrillation: when details matter.
Although the clinically manifest stroke rate related to pulmonary vein isolation (PVI) is rare and currently
Source: Heart Rhythm - July 23, 2018 Category: Cardiology Authors: Jacopo Marazzato, Roberto De Ponti Source Type: research
EP News: Allied Professionals
Using data on patients in the United States Renal Data System (USRDS), Siontis et al (Circulation 2018; https://doi.org/10.1161/CIRCULATIONAHA.118.035418 [Epub ahead of print], PMID 29954737) sought to assess patterns of apixaban use and outcomes related to use of anticoagulants in patients with end-stage renal disease (ESRD) and atrial fibrillation (AF). As background, patient s with ESRD have both higher risk of bleeding and higher risk of stroke with AF. The Food and Drug Administration has approved updated labeling for the use of apixaban in patients with ESRD on the basis of a small pharmacokinetic study.
Source: Heart Rhythm - July 26, 2018 Category: Cardiology Authors: Erica S. Zado Tags: EP News Source Type: research
Defibrillation testing and clinical outcomes after implantable cardioverter defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial
The Shockless IMPLant Evaluation (SIMPLE) showed that defibrillation testing (DT) at the time of implantable cardioverter defibrillator (ICD) implant did not improve shock efficacy or reduce mortality. There are no data regarding the risk of complications, including stroke, among patients with atrial fibrillation (AF) who undergo DT.
Source: Heart Rhythm - July 28, 2018 Category: Cardiology Authors: Stefan Bogdan, Michael Glikson, Stuart J. Connolly, Jia Wang, Stefan H. Hohnloser, Ursula Appl, Jorg Neuzener, Philippe Mabo, Xavier Vinolas, Frederick Gadler, Lieselot van Erven, Josef Kautzner, Brandi Meeks, Janice Pogue, Jeff S. Healey Source Type: research
Seeing is Believing: The Importance of Continuous Monitoring to Unmask the Real-World Atrial Fibrillation Recurrence after Ablation
Atrial fibrillation (AF) is a common arrhythmia encountered in clinical practice that contribute to hemodynamic abnormalities, thromboembolic events and hospitalizations.1 The prevalence of AF is around 1% in the general population, substantially increases with age and is estimated to reach 4% in 2050.2, 3 Compared with patients without AF, patients with AF has an increased risk of dementia (hazard ratio [HR]=1.56), myocardial infarction (HR=1.62), sudden cardiac death (HR=1.83), mortality (HR=2.61), heart failure (HR=3.31) and ischemic stroke (HR=3.34).
Source: Heart Rhythm - July 28, 2018 Category: Cardiology Authors: Ting-Yung Chang, Chin-Yu Lin, Shih-Ann Chen Source Type: research
Accessory Pulmonary Vein Insertion into the Left Atrial Appendage Revealed During Intended Interventional LAA Occlusion
A 64-year-old male with paroxysmal atrial fibrillation and a recent stroke presented with internal carotid artery re-stenosis after prior angioplasty. Cardiovascular risk factors included arterial hypertension, hyperlipidemia, obesity, positive family history, heart failure, and active smoking. Due to high risk of cerebral ischemia as well as periinterventional bleeding complications, the patient was scheduled for interventional left atrial appendage (LAA) closure prior to carotid artery surgery.
Source: Heart Rhythm - July 30, 2018 Category: Cardiology Authors: Octavian Maniuc, Jonas M üntze, Maria Moritz, Peter Nordbeck Source Type: research
Silent cerebral embolism in cryoballoon ablation of atrial fibrillation: When details matter
Although the clinically manifest stroke rate related to pulmonary vein isolation (PVI) is rare and currently
Source: Heart Rhythm - July 23, 2018 Category: Cardiology Authors: Jacopo Marazzato, Roberto De Ponti Tags: Editorial Commentary Source Type: research
Net Clinical Benefit of Anticoagulant Treatments in Elderly Patients with Non-Valvular Atrial Fibrillation: Experience From the Real World
Oral anticoagulation (OAC) is effective in stroke prevention in elderly patients with non-valvular atrial fibrillation (AF), but older patients are also at greater risk of bleeding.
Source: Heart Rhythm - August 17, 2018 Category: Cardiology Authors: Hilmi Alnsasra, Moti Haim, Adi Berliner Senderey, Orna Reges, Maya Leventer-Roberts, Yoav Arnson, Morton Leibowitz, Moshe Hoshen, Meytal Avgil-Tsadok Source Type: research
Defibrillation testing and clinical outcomes after implantable cardioverter –defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial
The Shockless IMPLant Evaluation (SIMPLE) trial showed that defibrillation testing (DT) at the time of implantable cardioverter –defibrillator (ICD) implant did not improve shock efficacy or reduce mortality. There are no data regarding the risk of complications, including stroke, among patients with atrial fibrillation (AF) who undergo DT.
Source: Heart Rhythm - July 28, 2018 Category: Cardiology Authors: Stefan Bogdan, Michael Glikson, Stuart J. Connolly, Jia Wang, Stefan H. Hohnloser, Ursula Appl, Jorg Neuzener, Philippe Mabo, Xavier Vinolas, Frederick Gadler, Lieselot van Erven, Josef Kautzner, Brandi Meeks, Janice Pogue, Jeff S. Healey Source Type: research
Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world
Oral anticoagulation (OAC) is effective in stroke prevention in elderly patients with nonvalvular atrial fibrillation (AF), but older patients are also at higher risk of bleeding.
Source: Heart Rhythm - August 17, 2018 Category: Cardiology Authors: Hilmi Alnsasra, Moti Haim, Adi Berliner Senderey, Orna Reges, Maya Leventer-Roberts, Yoav Arnson, Morton Leibowitz, Moshe Hoshen, Meytal Avgil-Tsadok Source Type: research
Anti-coagulation in Elderly Patients with Non-Valvular Atrial Fibrillation: A Balancing Act
Atrial fibrillation(AF) is a major global health burden due to its rising prevalence and associated complications such as stroke and mortality1. Approximately 33 million people were estimated to have AF in the 2010 Global Burden of Disease study but this number is projected to increase exponentially due to the ageing population1
Source: Heart Rhythm - September 18, 2018 Category: Cardiology Authors: Ameenathul Fawzy, Gregory Y.H. Lip Source Type: research
